Breastca-genetics
1 – 10 of 2176
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Analysis of human papillomaviruses and human polyomaviruses in lung cancer from Swedish never-smokers
-
The value of the Skåne Health-care Register : Prospectively collected individual-level data for population-based studies
Löfvendahl, Sofia LU ; Schelin, Maria E C LU and Jöud, Anna LU
(2020)
In Scandinavian Journal of Public Health
48(1).
p.56-63
Mark
- Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
-
Using Cards to Facilitate Conversations About Wishes and Priorities of Patients in Palliative Care
Möller, Ulrika Olsson LU ; Pranter, Christa ; Hagelin, Carina Lundh ; Beck, Ingela LU ; Malmström, Marlene LU
;
Fürst, Carl Johan
LU
and
Rasmussen, Brigit H.
LU
(2020)
In Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association
22(1).
p.33-39
Mark
-
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, Laura LU ; Westbom-Fremer, Sofia LU
;
Arildsen, Nicolai Skovbjerg
LU
;
Hartman, Linda
LU
;
Malander, Susanne
LU
;
Kannisto, Päivi
LU
;
Måsbäck, Anna
LU
and
Hedenfalk, Ingrid
LU
(2020)
In Virchows Archiv : an international journal of pathology
Mark
- Substantial intrinsic variability in chemoradiosensitivity of newly established anaplastic thyroid cancer cell-lines
- Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer : A Step in the Right Direction but Still a Long Way To Go.
- Leadership in specialist palliative home care teams : A qualitative study
- Difficult journeys in sarcoma care; socioeconomic disparity added to the multiple challenges of a rare tumor diagnosis
- Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness